I look forward to the new commercial manager who got loaded with some options to do the job. Until we get to $2 again, a takeover could happen (but too cheap still), but most of us like you want a proper growth business. Way better returns.
It good to see we finally have a bunch of inflection points coming up which will drive speculation.
DFU and GvHD look pretty safe bets to me given the early stage data we have seen in both.
Ann: CYP Presents at Major International Cell Therapy Conference, page-15
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $1.705K | 8.654K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12792 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 32500 | 1 |
View Market Depth
| Last trade - 10.02am 30/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |